We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

MHC Myhealthchecked Plc

-0.50 (-4.65%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Myhealthchecked Plc LSE:MHC London Ordinary Share GB00BN7K5L93 ORD 1.5P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.50 -4.65% 10.25 76,887 13:33:03
Bid Price Offer Price High Price Low Price Open Price
10.00 10.50 10.75 10.25 10.75
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Surgical,med Instr,apparatus 22.31M 1.52M 0.0292 3.51 5.33M
Last Trade Time Trade Type Trade Size Trade Price Currency
14:35:59 O 12 10.00 GBX

Myhealthchecked (MHC) Latest News

Myhealthchecked (MHC) Discussions and Chat

Myhealthchecked Forums and Chat

Date Time Title Posts
13/6/202411:47MyHealthChecked PLC to 100p9,931

Add a New Thread

Myhealthchecked (MHC) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type

Myhealthchecked (MHC) Top Chat Posts

Top Posts
Posted at 16/6/2024 09:20 by Myhealthchecked Daily Update
Myhealthchecked Plc is listed in the Surgical,med Instr,apparatus sector of the London Stock Exchange with ticker MHC. The last closing price for Myhealthchecked was 10.75p.
Myhealthchecked currently has 52,005,932 shares in issue. The market capitalisation of Myhealthchecked is £5,330,608.
Myhealthchecked has a price to earnings ratio (PE ratio) of 3.51.
This morning MHC shares opened at 10.75p
Posted at 07/6/2024 08:53 by tia01
GDR has a Market cap of 9m. Burning cash at an astonishing rate! Just raised 6m at 1.5p killing shareholders value.

MHC had nearly 8m in the bank at of 2023. Probably increased 1m with cost cutting despite slowing covid sales.
Intends to expand into another 200Boots stores and open new revenue streams in B2B and phlebotomy testing!
No capital needed as fully funded.

Is the Market really against MHC or is the fact we have a female CEO part of the reason.
Sorry for being blunt but any other company with figures like MHC would be 3x current price in a male run business whether it was run prudent or not.
Stand up for Penny and pile in.
Get behind her as she is no fool and like most women in the household knows how to take care of the finances. Go Penny and turn into pounds
Posted at 04/6/2024 17:30 by tia01
Listening was interesting and it would appear they are working on a few things which Penny said they intend to share with the market over coming months!. Maybe one reason they can’t buy shares if they have price sensitive information.
Seems like B2B with insurance is area of potential growth. Still happy with cash position penny says and self sufficient. I bet if share rose suddenly we could see and acquisition and capital raise. Not quite what to make when asked about ABDX. LFT tests never seemed to be her main focus.
Nothing said from Chairman.
Honestly I can’t believe how low share price is on cash alone compared to competitors and their positions financially and market caps out there. Maybe this may change and they may get some credit for being self sufficient and not needing to dilute over the years.
Most investors bailed already after huge losses and I don’t believe any investors making any capital return on investment so far. Far to say you must believe share price can go use from these levels but who knows
Posted at 01/6/2024 10:39 by tia01
You summed it up well. It’s a shame the markets keep selling it off. I see ABDX bought a company using shares etc. MHC have cash and need to do something with it to help expand more rapidly whilst many companies struggling. Now could be a time for an acquisition given how cheap many companies are. I’m sure the board have evaluated this and well aware of the opportunities out there. For me I I just hope the board don’t just rely on Boots because IMO Boots doing deals with ABDX shows they have no loyalty to MHC products. I do believe an incoming Labour Party may wish to get waiting list and cost down regards GPs etc and if MHC products were to be made available to Boots Pharmacy for prescription to use in conjunction with Boots trained pharmacy staff then MHC and Boots could have a huge beneficial and meaningful relationship. That depends on the Government as shown in recent changes in some products be prescribed in Boots. I do worry that Penny and the board are not focusing on investors Importance and value. I say this because since lockdown many of us are 90% down so a rise of 10% has no impact. Also lack of news offers little incentive to average down. I hope they truly offer something to change this and can demonstrate organic growth in revenue out side of Covid products giving optimism to the markets. We mustn’t take away how well Penny and the board have done growing the cash position whilst being self sufficient and not needing to return to the market for capital raises. This in itself is a major success however the market will be focusing on the growth potential in revenue and ability to convert it to profit.
Posted at 25/5/2024 08:15 by tia01
I recall when it was announced Donald had a 3% stake it rocketed to near 15p! From lows. Maybe he should have cashed in.

Can Penny offer any good news and support to the share price!. Strange but crazy to think MHC has remained in a healthy position financially through a difficult period of high inflation and interest rates that had destroyed many other businesses.

Can MHC demonstrate growth and a path to expand revenue through new products to convince the markets it truly is a growth story or will they judge it on Covid revenue alone.

That said Covid revenue up to 31st December was solid however new product sales growth is the true figure MHC may be judged on.

Either way it’s been a painful time for holders of MHC over the last few years.
Posted at 15/5/2024 17:11 by tia01
The radio silence is reflected in the share price and surely the board can see this. All I can say is given our financial position I feel the markets have it wrong with competitors valuations as to MHC.
However market work off updates and PR etc so MHC should realise this is having a devastating effect of share holders
Posted at 18/3/2024 07:55 by tia01
After comparing MHC and ABDX you can’t help notice quite a few points.
ABDX market cap over 10m
MHC over 6.5m

ABDX has around 1.9m
MHC has around 8m plus

ABDX has a high cash burn and needed fund raises.

MHC is prudent and cash in the bank growing.

ABDX concentrated on revenue growth.
MHC concentrated on cash flow and growth.

ABDX main product is salistick
MHC has over 20 Products

So is
ABDX Market Cap of 10m justified! Or is MHCs 6.5m way undervalued!

Hopefully end of year results will show growth for MHC and we push up to levels of our competitors to reflect the facts.
Posted at 02/3/2024 21:33 by tia01
Could ABDX be vulnerable to a takeover given share price keeps falling and the cash burn rate.
They could be potentially be a good fit for MHC who has cash and knowledge of the pregnancy test market which ABDX has developed a great product in. Maybe not a direct takeover but some sort of collaboration. MHC would be able to expand its product base into various places ABDX has established itself due to the salistick it’s developed. This one catching my eye because it’s burning cash whilst concentrating on revenue over profit.
It finance situation makes it a takeover target or a strategic alliance candidate for someone like MHC
Posted at 21/2/2024 19:37 by tia01
Black horse
Without being disrespectful but Money obviously moving to MHC which is why we are 50% up from December roughly.
Given we are on MHC site I’m happy to discuss money inflowing to MHC.
All be it I wish a bit bit quicker lol.
The fact is it’s ticking up without any one noticing it so hopefully a good RNS will come and get MHC noticed.
I do see resistance at 16-17p if we get there as this was the figure around the time we fell early 2023 when the poor figures landed.
I do however feel whilst we have seen a slowdown in covid sales that it’s possible new products are gaining traction.
I do think a explanation as to why some of the good likes like intolerance tests are out of stock for so long online but can only assume that potential buyers will still go to stores nearby or use MHCs site directly.
I feel the next set of results will be a much better set than lasts years. More cash in the bank and I have a sneaky feeling we are probably going to drop news on a few new products in my opinion.
Also need a plan to move more expensive ones otherwise you have to judge if production costs are worth it in the sales figures given they have shelf life expiring dates.
Also is MHC a takeover target with cash situation and no debts.
I just wonder why Directors not buying and wonder if they are excluded because they are privileged to News coming.
All my own personal beliefs but hopefully something soon to take it up to the next level and back to 25p plus as Spacedust said
Posted at 06/2/2024 18:35 by tia01
So that’s 6% of the current shares taken off the market for investing £400,000 from interest which still leaves the company with well over 7.5m to continue its expansion.
The board passed a resolution early in 2023 to be allowed to buy up to 10% of shares back. We could buy back 6% with interest alone. This is a smart way to create investor value and company value with increased share price which increases the power and ability to expand with a higher share price!
Posted at 17/1/2024 08:21 by tia01
25% drop in share price from recent highs!
Is it reasonable to say the selling overdone.
Dropped 25% on less than £25,000 worth of shares sold.
So a quarter of the market capital erased.

You can’t make it up.
Extra 2.75m in the bank
£25,000 shares sold in 4 days
Decline in share price 25%.

Sometimes things justify price action and this is clearly one of them times.

I suspect it’s attracting attention at these levels shortly
Myhealthchecked share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock